Quali sono gli orari di apertura?

Lunedì 09:00 - 18:00 Martedì 09:00 - 18:00 Mercoledì 09:00 - 18:00 Giovedì 09:00 - 18:00 Venerdì 09:00 - 18:00

IFSO

The International Federation for the Surgery and other Therapies for Obesity (IFSO)

IFSO is growing into a professional organization, with the goal to support its members in aspects directly related to their profession. IFSO's main activity is currently the organization of the yearly World Congress, which provides a forum to exchange knowledge on surgical treatment of severely obese patients, to present new techniques, research and concepts, and to meet the experts in the field. VISION
“To optimize the control of adiposity-based chronic diseases.”
MISSION
“To unify the global scientific, surgical and integrated health communities, for the purpose of dissemination of knowledge, collaboration and establishing universal standards of care for the treatment of individuals with adiposity-based chronic disease.”

19/12/2025

La experiencia de Nerea, de 20 años, muestra cómo la Bariatric Surgery puede transformar la vida incluso a una edad muy joven. Comenzó con 150 kg y hoy está en 100, con 50 kg menos y un cambio físico y emocional enorme. Cuenta que antes se cansaba con facilidad al hacer ejercicio y que ahora su energía, movilidad y confianza han mejorado significativamente.
Su caso recuerda que tratar la obesidad de forma temprana puede devolver salud, vitalidad y nuevas oportunidades.

________________

Nerea, 20 years old, shows how Metabolic Bariatric Surgery can positively transform life even at a young age. She started at 150 kg and is now at 100, having lost 50 kg with a remarkable change in her health and daily life. She shares that exercise used to exhaust her, while now her energy, mobility and confidence have improved dramatically.
Her journey highlights how early treatment of obesity can restore health, vitality and new possibilities.

17/12/2025

As Dr. Cohen explains, the new international consensus clarifies how anti-obesity medications should be used alongside Metabolic Bariatric Surgery.

The message is simple:
Before surgery: AOMs can be considered, but there isn’t enough strong evidence to recommend routine use.

After surgery: They may help optimize outcomes, though more research is needed to know who benefits most.

Before revisional surgery: Medications and endoscopic options can be considered before moving to another operation.

Dr. Cohen emphasizes that the priority remains the same:
personalized, evidence-based care for every patient.

15/12/2025

The idea that Metabolic Bariatric Surgery (MBS) is “the easy way out” is a persistent myth.

In reality, MBS triggers profound hormonal and metabolic changes that no diet alone can achieve.
Patients continue to work hard on nutrition, activity, and long-term follow-up.
It is not a shortcut, it is evidence-based medical care.

IFSO works to end stigma and promote accurate understanding of obesity treatment.

12/12/2025

La historia de Maria refleja lo que puede significar la Metabolic Bariatric Surgery en la vida de una persona. A los 42 años comenzó su proceso con 122 kg y, seis meses después, está cerca de los 75 kg. Cuenta que la recuperación fue más sencilla de lo que imaginaba, que hoy puede realizar actividades que antes no eran posibles y que no se arrepiente de haber dado este paso.
Su experiencia recuerda que, con el tratamiento adecuado, es posible recuperar salud, movilidad y bienestar.

___

Maria’s journey shows the real impact of Metabolic Bariatric Surgery. At 42, she started her process at 122 kg, and six months later she is close to 75 kg. She shares that recovery was easier than expected, she can now enjoy activities she couldn’t do before, and she has no regrets about choosing surgery.
Her story highlights how the right treatment can restore health, mobility, and quality of life.

10/12/2025

Dr. Ponce reminds us of a critical reality: obesity is not just excess weight.
It is a medical disease that increases the risk of type 2 diabetes, high blood pressure, bone and joint problems, heart disease, and even several types of cancer.

What many people don’t realize is that Metabolic Bariatric Surgery can significantly improve many of these conditions.
Type 2 diabetes can enter remission, blood pressure can normalize, and the risk of cancer and cardiovascular disease can be meaningfully reduced.

As Dr. Ponce explains, when obesity is treated at its root, many of the health problems linked to it begin to improve, or even resolve.
This is why IFSO emphasizes one key message:
addressing obesity first is one of the most effective ways to protect a person’s overall health.

08/12/2025

Hypertension is one of the most common complications of obesity.

After metabolic and bariatric surgery, many patients see blood pressure normalize or require fewer medications.

Why? Reduced inflammation, improved insulin sensitivity, and better metabolic function all support cardiovascular health.

IFSO encourages timely treatment to protect the heart.

06/12/2025

Exciting milestone for IFSO
Today we launched the pilot IFSO Robotic Bariatric Surgery Fellowship in Atlanta with four fellows from the Latin America region. This initiative was created under the leadership of Ricardo Cohen, with Rana Pullatt leading the task force and myself coordinating the program.
Thanks to our partnership with Intuitive Surgical each fellow will train on a dedicated robotic system, complete ≥30 mentored cases, and follow a structured didactic curriculum.
Next week, three fellows from Europe will begin their training in Freiburg, Germany, completing this global pilot.
Proud of the impact this program will bring to Brazil, Mexico, Ecuador, and Europe (Italy and Spain).

05/12/2025

Los testimonios como el de Diana muestran cómo la Metabolic Bariatric Surgery puede transformar la salud, la movilidad y la calidad de vida. El tratamiento adecuado no solo ayuda a perder peso: devuelve bienestar, energía y la posibilidad de vivir plenamente.
____________
Stories like Diana’s show how Metabolic Bariatric Surgery can restore health, mobility and quality of life. The right treatment isn’t just about weight loss; it brings back wellbeing, energy, and the chance to live fully.

03/12/2025

Metabolic Bariatric Surgery (MBS) is often perceived as risky, but the data tell a very different story.
As Dr. Alex Craven explains, every operation carries some level of risk, yet leaving clinical obesity untreated is far more dangerous.

Evidence shows that, in individuals without diabetes, Metabolic Bariatric Surgery can reduce the risk of death by 30–40%.
For patients with diabetes, the reduction in mortality approaches 70%.

This is why IFSO emphasizes a simple truth:
MBS is not a dangerous option: when clinically indicated, it is one of the safest and most effective ways to protect long-term health.

01/12/2025

Visceral fat isn’t visible, but its impact is serious.

It fuels chronic inflammation, increases the risk of type 2 diabetes and cardiovascular disease, and accelerates metabolic decline.

The good news? It responds exceptionally well to Metabolic Bariatric Surgery, which reduces visceral fat and restores metabolic health.

IFSO promotes early, evidence-based treatment to prevent long-term complications.

28/11/2025

Obesity is not your fault. It is a chronic disease that we at IFSO address every day through scientific communication and public education, to remind you that you are not alone and that evidence-based therapeutic options exist to help you overcome this condition—foremost among them bariatric surgery.

This is the statement of Dr. Khaled Gawdat, the newly appointed President of IFSO.

Indirizzo

Rione Sirignano, 5
Naples
80121

Orario di apertura

Lunedì	09:00 - 18:00
Martedì	09:00 - 18:00
Mercoledì	09:00 - 18:00
Giovedì	09:00 - 18:00
Venerdì	09:00 - 18:00

Telefono

+39 081 7611085

Sito Web

http://www.ifso.com/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando IFSO pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.